biote Corp.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $44.2M | $44.9M | $46.4M | $48.0M | $48.9M | $49.0M | $49.8M | $51.4M |
| Cost of Revenue | $15.3M | $14.0M | $14.8M | $13.5M | $13.9M | $12.6M | $14.0M | $15.3M |
| Gross Profit | $28.9M | $31.0M | $31.6M | $34.4M | $35.0M | $36.4M | $35.8M | $36.1M |
| Gross Margin | 65.4% | 68.9% | 68.0% | 71.8% | 71.6% | 74.3% | 71.8% | 70.3% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $32.4M | $27.8M | $24.7M | $26.2M | $24.2M | $26.7M | $33.0M | $23.9M |
| Operating Income | $-3.5M | $3.2M | $6.8M | $8.3M | $10.8M | $9.7M | $2.8M | $12.2M |
| Operating Margin | -7.9% | 7.0% | 14.7% | 17.2% | 22.0% | 19.8% | 5.6% | 23.7% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-7.1M | $3.3M | $5.6M | $8.5M | $6.1M | $17.5M | $-1.2M | $15.9M |
| Income Tax Expense | $296.0K | $662.0K | $3.0M | $-765.0K | $2.2M | $1.6M | $-4.7M | $3.2M |
| Net Income | $-6.6M | $2.3M | $2.0M | $8.2M | $3.2M | $13.7M | $3.7M | $10.7M |
| Net Margin | -14.8% | 5.1% | 4.2% | 17.1% | 6.5% | 28.0% | 7.4% | 20.8% |
| EPS (Basic) | $-0.23 | $0.07 | $0.06 | $0.26 | $0.10 | $0.44 | $0.08 | $0.34 |
| EPS (Diluted) | $-0.23 | $0.06 | $0.05 | $0.22 | $0.10 | $0.37 | $0.09 | $0.33 |
| Shares Outstanding (Basic) | 28.6M | 30.6M | 31.3M | 31.3M | 31.6M | 31.5M | 34.3M | 31.0M |
| Shares Outstanding (Diluted) | 28.6M | 36.0M | 36.7M | 36.7M | 31.7M | 37.0M | 34.3M | 32.3M |
| Dividends Per Share | — | — | — | — | — | — | — | — |